This American Gastroenterological Association (AGA) clinical practice update provides best practice advice on evidence-based approaches diagnosis, staging, and management of NAFLD in lean individuals. It recommends combining noninvasive biomarkers, such as cT1, with fibrosis tests (VCTE, MRE, and EFL) to identify and risk-stratify lean patients with NASH for most appropriate treatment.
Welcome to Perspectum Medical Education
You are entering a website that is scientific in nature and created for healthcare professionals.
Are you a healthcare professional?